Novanta Inc. (NOVT) Price Target Analysis
Updated Jun 18, 2026
Analyst Rating: Buy
Based on 3 analysts15.9% Below Target
NOVT trades 15.9% below Wall Street's consensus target of $180.00.
Current Price$155.30
Average Target$180.00
Low$180.00
Median$180.00
High$180.00
Analyst Target Range
Forward P/E43.3x
(Growth Premium)
PEG Ratio13.13
(Expensive)
Implied Growth+175.1%
(High Growth)
Analyst Spread0.0%
(High Agreement)
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Consensus Scenario Assumptions
The base valuation assumes NOVT achieves its forward estimates and maintains a stable P/E multiple of 43.3x. This scenario reflects the blended consensus of 3 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
NOVT Price Target Analysis
Updated June 20, 2026As of June 20, 2026, Novanta Inc. (NOVT) has a Wall Street consensus price target of $180.00, based on estimates from 3 covering analysts. With the stock currently trading at $155.30, this represents a potential upside of +15.9%. The company has a market capitalization of $5.53B.
Analyst price targets range from a low of $180.00 to a high of $180.00, representing a 0% spread in expectations. The median target of $180.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 2 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, NOVT trades at a trailing P/E of 105.6x and forward P/E of 43.3x. The forward PEG ratio of 13.13 reflects a premium valuation. Analysts expect EPS to grow +175.1% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $94.32, with bear and bull scenarios of $59.42 and $124.27 respectively. Model confidence stands at 42/100, suggesting limited visibility into future performance.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Technology stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside
-1.3%
Industry Consensus
Avg Forward P/E
57.5x
(High Premium)
Peers with Coverage
10 / 10
Active Analyst Tracking
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 MKSIMKS Inc. | $27.4B | $406.37 | $322.00 | -20.8% | Buy | 34.7x | 29 |
 CGNXCognex Corporation | $11.0B | $66.10 | $70.92 | +7.3% | Buy | 44.5x | 31 |
 COHRCoherent, Inc. | $61.8B | $389.57 | $324.00 | -16.8% | Buy | 71.4x | 30 |
 KLICKulicke and Soffa Industries, Inc. | $6.4B | $121.87 | $70.00 | -42.6% | Buy | 35.7x | 11 |
 IPGPIPG Photonics Corporation | $5.0B | $118.01 | $151.50 | +28.4% | Buy | 92.9x | 27 |
 AEISAdvanced Energy Industries, Inc. | $14.2B | $372.59 | $367.86 | -1.3% | Buy | 40.0x | 24 |
 LSCCLattice Semiconductor Corporation | $21.1B | $153.72 | $141.11 | -8.2% | Buy | 146.4x | 17 |
 VIAVViavi Solutions Inc. | $10.9B | $47.17 | $32.25 | -31.6% | Buy | 50.3x | 19 |
 ISRGIntuitive Surgical, Inc. | $144.5B | $406.78 | $597.78 | +47.0% | Buy | 38.9x | 55 |
 SYKStryker Corporation | $117.9B | $307.80 | $387.46 | +25.9% | Buy | 20.5x | 51 |
NOVT — Frequently Asked Questions
Quick answers to the most common questions about buying NOVT stock.
What is the NOVT stock price target for 2026?
Novanta Inc. (NOVT) has a consensus 12-month price target of $180, implying 15.9% upside from $155.3. The 3 analysts covering NOVT see moderate appreciation potential.
Is NOVT a buy, sell, or hold?
NOVT has a consensus rating of "Buy" based on 3 Wall Street analysts. The rating breakdown is predominantly bullish, with 2 Buy/Strong Buy ratings. The consensus 12-month price target of $180 implies 15.9% upside from current levels.
Is NOVT stock overvalued or undervalued?
At a forward P/E of 43.2591x, NOVT trades at a premium valuation. The consensus price target of $180 (15.9% upside) suggests analysts still see growth justifying the multiple.
How high can NOVT stock go?
The most bullish Wall Street analyst has a price target of $180 for NOVT, while the most conservative target is $180. The consensus of $180 represents the median expectation. Our quantitative valuation model projects a bull case target of $124 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
How many analysts cover NOVT stock?
NOVT is lightly followed, with 3 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 1 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the NOVT stock forecast?
The 12-month NOVT stock forecast based on 3 Wall Street analysts shows a consensus price target of $180, with estimates ranging from $180 (bear case) to $180 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $94, with bear/bull scenarios of $59/$124.
What is NOVT's fair value based on fundamentals?
Our quantitative valuation model calculates NOVT's fair value at $94 (base case), with a bear case of $59 and bull case of $124. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 42/100.
What is NOVT's forward P/E ratio?
NOVT trades at a forward P/E ratio of 43.3x based on next-twelve-months earnings estimates compared to a trailing P/E of 105.6x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy NOVT stock?
Wall Street analysts are optimistic on NOVT, with a "Buy" consensus rating and $180 price target (15.9% upside). 2 of 3 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do NOVT price targets vary so much?
NOVT analyst price targets range from $180 to $180, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $180 consensus represents the middle ground. Our model's $59-$124 range provides an independent fundamental perspective.
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare